BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11406562)

  • 1. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium.
    Glinsky VV; Glinsky GV; Rittenhouse-Olson K; Huflejt ME; Glinskii OV; Deutscher SL; Quinn TP
    Cancer Res; 2001 Jun; 61(12):4851-7. PubMed ID: 11406562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
    Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
    Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium.
    Glinsky VV; Glinsky GV; Glinskii OV; Huxley VH; Turk JR; Mossine VV; Deutscher SL; Pienta KJ; Quinn TP
    Cancer Res; 2003 Jul; 63(13):3805-11. PubMed ID: 12839977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.
    Zou J; Glinsky VV; Landon LA; Matthews L; Deutscher SL
    Carcinogenesis; 2005 Feb; 26(2):309-18. PubMed ID: 15528216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin.
    Dimitroff CJ; Lechpammer M; Long-Woodward D; Kutok JL
    Cancer Res; 2004 Aug; 64(15):5261-9. PubMed ID: 15289332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries.
    Peletskaya EN; Glinsky VV; Glinsky GV; Deutscher SL; Quinn TP
    J Mol Biol; 1997 Jul; 270(3):374-84. PubMed ID: 9237904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Golgi pH in breast and colorectal cancer cells correlates with the expression of oncofetal carbohydrate T-antigen.
    Rivinoja A; Kokkonen N; Kellokumpu I; Kellokumpu S
    J Cell Physiol; 2006 Jul; 208(1):167-74. PubMed ID: 16547942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions.
    Khaldoyanidi SK; Glinsky VV; Sikora L; Glinskii AB; Mossine VV; Quinn TP; Glinsky GV; Sriramarao P
    J Biol Chem; 2003 Feb; 278(6):4127-34. PubMed ID: 12438311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells.
    Glinskii OV; Turk JR; Pienta KJ; Huxley VH; Glinsky VV
    J Physiol; 2004 Jan; 554(Pt 1):89-99. PubMed ID: 14678494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells.
    Ugorski M; Laskowska A
    Acta Biochim Pol; 2002; 49(2):303-11. PubMed ID: 12362971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of cytotoxic T lymphocytes specific for the prostate and breast tissue antigen TARP.
    Carlsson B; Tötterman TH; Essand M
    Prostate; 2004 Oct; 61(2):161-70. PubMed ID: 15305339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner.
    Kobayashi H; Nagato T; Sato K; Aoki N; Kimura S; Murakami M; Iizuka H; Azumi M; Kakizaki H; Tateno M; Celis E
    Cancer Res; 2007 Jun; 67(11):5498-504. PubMed ID: 17545632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of H type 1 carbohydrate antigen in cell adhesion to vascular endothelial cells of human endometrial cancer.
    Sakuma Y; Kubushiro K; Tsukazaki K; Nozawa S
    Anticancer Res; 2003; 23(2B):1277-82. PubMed ID: 12820383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells.
    Draffin JE; McFarlane S; Hill A; Johnston PG; Waugh DJ
    Cancer Res; 2004 Aug; 64(16):5702-11. PubMed ID: 15313910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium.
    Barrow H; Guo X; Wandall HH; Pedersen JW; Fu B; Zhao Q; Chen C; Rhodes JM; Yu LG
    Clin Cancer Res; 2011 Nov; 17(22):7035-46. PubMed ID: 21933892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.
    Inohara H; Akahani S; Koths K; Raz A
    Cancer Res; 1996 Oct; 56(19):4530-4. PubMed ID: 8813152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
    Freire T; Bay S; von Mensdorff-Pouilly S; Osinaga E
    Cancer Res; 2005 Sep; 65(17):7880-7. PubMed ID: 16140958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
    Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
    Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy.
    Machlenkin A; Paz A; Bar Haim E; Goldberger O; Finkel E; Tirosh B; Volovitz I; Vadai E; Lugassy G; Cytron S; Lemonnier F; Tzehoval E; Eisenbach L
    Cancer Res; 2005 Jul; 65(14):6435-42. PubMed ID: 16024648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.